Malnutrition syndrome, but not body mass index, is associated to worse prognosis in heart failure patients

Clinical Nutrition

Volumn 30, Issue 6, 2011, Pages 753-758

  Colín Ramírez, Eloisa ^a   Orea Tejeda, Arturo ^a   Castillo Martínez, Lilia ^a   Montaño Hernández, Patricia ^a   Sánchez Ramírez, Anahí ^a   Pineda Juárez, Juan Antonio ^a   Rebollar González, Verónica ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Body composition; Handgrip strength; Heart failure; Obesity paradox; Prognosis; Survival

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; HEMOGLOBIN;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMICAL COMPOSITION; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; GRIP STRENGTH; HEALTH STATUS; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; OBESITY; PROGNOSIS; SEX DIFFERENCE; SYSTOLIC HEART FAILURE; UNDERWEIGHT;

ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; ELECTRIC IMPEDANCE; FEMALE; HAND STRENGTH; HEART FAILURE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MALNUTRITION; MEXICO; RETROSPECTIVE STUDIES;

EID: 82255191799     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.07.005     Document Type: Article

References (31)

1. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67(5):968-977.
2. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 2002, 347(5):305-313.
3. Arena R., Lavie C.J. The obesity paradox and outcome in heart failure: is excess body weight truly protective?. Future Cardiol 2010, 6(1):1-6.
4. Lavie C.J., Romero-Corral A. Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the " obesity paradox" Mayo Clin Proc 2010, 85(7):605-608.
5. Kalantar-Zadeh K., Block G., Horwich T., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439-1444.
6. Oreopoulos A., Ezekowitz J.A., McAlister F.A., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010, 85(7):609-617.
7. Androne A.S., Katz S.D., Lund L., LaManca J., Hudaihed A., Hryniewicz K., et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003, 107(2):226-229.
8. Colín-Ramírez E., Castillo-Martínez L., Orea-Tejeda A., Asensio Lafuente E., Torres Villanueva F., Rebollar González V., et al. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients. Clin Nutr 2006, 25(5):746-757.
9. Chaney E., Shaw A. Pathophysiology of fluid retention in heart failure. Contrib Nephrol 2010, 164:46-53.
10. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002, 39:1780-1786.
11. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult A report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.
12. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual, abridged edition 1991, Human Kinetics Books, Champaign, IL.
13. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985, 41:810-817.
14. Piccoli A., Nescolarde L.D., Rosell J. Análisis convencional y vectorial de bioimpedancia en la práctica clínica. Nefrologia 2002, 22:228-238.
15. Piccoli A., Rossi B., Pillon L., Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 1994, 46:534-539.
16. Espinosa M.A., Rivas L., González E.C., Atilano X., Miranda P., Correa-Rolter R. Vectores de impedancia bioeléctrica para la composición corporal en población mexicana. Rev Invest Clin 2007, 59:15-24.
17. Piccoli A., Pillon L., Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 2002, 18(2):153-167.
18. Hannan W.J., Cowen S.J., Plester C.E., Fearon K.C.H., Debeau A. Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (Lond) 1995, 89(6):651-658.
19. Campbell I.T., Han Bolton M., Nightingale P., Columb M.O., Brookes S.J. The use of multiple frequency bioimpedance to assess fluid balance in critical illness. Proc Nutr Soc 1998, 53:62A.
20. Bioelectrical impedance method in clinical research: a follow-up to the NIH technology assessment conference. Nutrition 1999, 15:874-880.
21. New York Heart Association Disease of the heart and blood vessels. Nomenclature and criteria for diagnosis 1964, Little, Brown, Boston, p. 114. 6th ed.
22. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., McAlister F.A. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156(1):13-22.
23. Cicoira M., Maggioni A.P., Latini R., Barlera S., Carretta E., Janosi A., et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail 2007, 9(4):397-402.
24. Lavie C.J., Osman A.F., Milani R.V., Mehra M.R. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003, 91(7):891-894.
25. Arena R., Myers J., Abella J., Pinkstaff S., Brubaker P., Moore B., et al. Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 2009, 104(8):1116-1121.
26. Gustafsson F., Kragelund C.B., Torp-Pedersen C., Seibaek M., Burchardt H., Akkan D., et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005, 26(1):58-64.
27. Izawa K.P., Watanabe S., Osada N., Kasahara Y., Yokoyama H., Hiraki K., et al. Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure. Eur J Cardiovasc Prev Rehabil 2009, 16(1):21-27.
28. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Woo M.A., Tillisch J.H. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001, 38(3):789-795.
29. Davos C.H., Doehner W., Rauchhaus M., Cicoira M., Francis D.P., Coats A.J., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003, 9(1):29-35.
30. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American heart association scientific statement on obesity and heart disease from the Obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation 2006, 113(6):898-918.
31. Cohn J.N., Tognoni G., Glazer R.D., Spormann D., Hester A. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail 1999, 5:155-160.